Sanofi (SNW.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 101.34B |
| Enterprise Value | 114.28B |
| P/E Ratio | 12.45 |
| PEG Ratio | -0.82 |
| Price/Sales Ratio | 1.96 |
| Price/Book Ratio | 1.28 |
| Enterprise/Revenue | 2.26 |
| Enterprise/EBITDA | 12.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 43.63B |
| Revenue/Share | 39.32 |
| Gross Profit | 28.66B |
| EBITDA | 17.09B |
| Net Income | 7.81B |
| Diluted EPS | 4.25 |
Balance Sheet
| Total Cash | 5.54B |
| Total Cash/Share | 4.6 |
| Total Debt | 20.02B |
| Total Debt/Equity | 0.27 |
| Current Ratio | 1.01 |
| Book Value Per Share | 60.74 |
Price History
| 52-Week Change | -7.78 |
| 52-Week High | 90.75 |
| 52-Week Low | 71.25 |
| Moving Average 50 Days | 75.14 |
| Moving Average 200 Days | 80.47 |
Statistics
| Average Volume | 14,711 |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.12 |
| Trailing Annual Dividend Yield | 5.34 |
| Payout Ratio | 0.63 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
